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SUMMARY ∑ A several-fold increase in the incidence of lung cancer during the last 20 years has
been obvious in the central Dalmatia region. It has been on a constant increase in both men and
women. A 2.4-fold increase has been recorded in male, and 4.2-fold in female population. The ma-
jority of patients are long-time cigarette smokers. Thirty years ago this habit was characteristic for
men, while today the number of female smokers has been on an increase (the percentage of female
patients cigarette smokers increased from 17.8% to 47.3%). Most patients are older than 65 and to-
gether with those over 60 years of age they make over 42% of lung carcinoma patients. The increased
incidence of adenocarcinoma not directly connected with cigarette smoking, on the account of a
decrease in the incidence of squamous cell carcinoma of the lung has been confirmed. The highest
increase was recorded during the postwar years (by as much as 32% in 2000), which could be attrib-
uted to severe psychical traumas and other hardships related to the war and life in the postwar pe-
riod. The increase in the incidence of squamous cell carcinoma in women (from 17.5% to 20.4%)
could probably be attributed to the increase in the number of female smokers. The decrease in the
incidence of small cell anaplastic lung carcinoma was evenly distributed in both sexes (from 27% to
22.6%). Comparison of data obtained for one part of Croatia (coastal region) with global data sug-
gests a similar epidemiological pattern to exist in the south and southeast Europe (south Italy, Spain,
Greece).
Introduction
The first description of lung cancer appeared in the
15th century, after a mine in Schneelberg, Germany, had
been opened, and it was referred to as “mountain sick-
ness”. Numerous authors considered lung cancer as sar-
comas.
Only 90 years ago (in 1912), Adler wrote the first
monograph on lung cancer, he apologized for writing
about such a rare disease, and expressed his doubt whether
it should have been written about at all (cited from ref. 1)1.
It was in the very next year that some authors, Weller
being one of them, found 89 cases of bronchial and lung
cancer worldwide2. During the last 50 years, lung cancer
has convincingly taken primacy among the causes of death
from malignant diseases in male population worldwide,
while a considerable increase has been recorded in
women6,12,14,21,23.
Lung cancer is posing an ever increasing medical and
social problem due to its increasing morbidity and mor-
tality. Treatment results are not encouraging, and the treat-
ment is a painstaking and expensive process. Annual
mortality rate could be regarded as annual morbidity rate
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since the annual rate of persons affected by the disease
almost equals the number of deaths1,3,7,8. In the risk
groups of population, the disease has been assuming char-
acteristics of an epidemic, so permanent follow-up of its
incidence and spread is imperative if the epidemiological
data are to be used to fight this disease and cancer in gen-
eral3.
It is beyond doubt that one of the basic etiologic fac-
tors of lung cancer is cigarette smoking, i.e. tobacco
smoke. Auerbach confirmed this in tests on dogs4. The
risk of bronchial and lung cancer grows proportionally
with the daily consumption of cigarettes and years of
smoking. According to Kubik’s study, the smokers be-
tween 60 and 64 years of age who smoked 200,000 ciga-
rettes during their life suffer from this disease 50 times,
and those who smoked under 200,000 cigarettes suffer 10
times more often than the non-smokers5.
The risk in smokers who quit smoking decreases to
reach the non-smoker risk level only after 15 years. Pas-
sive smokers are also exposed to a higher risk of lung can-
cer. The Japanese author Hirayami maintains that the
incidence of lung cancer in smokers’ wives is 2.8 times
higher than in non-smokers’ wives6,22.
Other inhalation factors can also contribute to the
incidence of lung cancer, the best known being asbestos,
uranium, tar, nickel, cobalt, chromium, arsenic, radioac-
tive radiation, vinyl-chloride, and other detrimental car-
cinogenic factors from the living and particularly work-
ing environment. The psychophysical condition of the
body contributes to the incidence of malignant diseases,
including lung cancer.
Patients and Methods
The analyzed patients were treated at the Department
for Pulmonary Diseases, Split Clinical Hospital, as out-
patients or inpatients during the last 12 years, and their
results were compared with the data previously collected
and processed (1981-1983) in a master’s thesis. The ar-
eas covered by the study were: the City of Split, Kaπtela,
Solin, Trogir, Sinj, Omiπ, Makarska, MetkoviÊ, PloËe,
Vrgorac and the islands of BraË, ©olta, Hvar, Vis, »iovo
and Drvenik, partly the island of KorËula, and Drniπ and
Knin town areas. This area mostly corresponds to the
present borders of the Split-Dalmatia County, a major
part of the Dubrovnik-Neretva County (PloËe and
MetkoviÊ, island of KorËula), and a part of the ©ibenik-
Knin County (greater area of Drniπ and Knin). During
the war and several years after the war, the share of refu-
gees and population from the neighboring Bosnia and
Herzegovina (particularly of those from west Bosnia and
Herzegovina) was large. They are presented separately in
the total number of patients.
The 20-year period was divided into three study pe-
riods: pre-war period 1981-1983; war period 1991∑1993;
and postwar period 1999-2001.
The data obtained were statistically analyzed by
Student’s t-test and Mann-Whitney U test.
Results
During the first study period (20 years ago), 352 per-
sons were affected by lung cancer in three years. Out of
352 patients, 321 (91.2%) were male and 31 (8.8%) fe-
male. The male/female ratio was 10.4:1. The majority of
patients were 60-64 years of age (18%) (58/321). The
incidence of affected men in this group was 292 (292/
100,000 male of this age). The majority of women, 21%
(7/31) fell ill between 55-59 years of age, yielding an in-
cidence of 24 patients per 100,000 women of that age.
Only 0.8% (3/352) patients fell ill at the age of 40, but
as many as 4.5% (16/352) at the age of 40-44. The inci-
dence at the then City of Split territory (including Kaπtela
and Solin municipalities) was 62.5/100,000 inhabitants.
In 96% of cases, the patients contacted their doctors
because of health problems or disease symptoms they felt.
In 3.6% of patients, the disease was detected accidentally.
Approximately 80.5% (284/352) of patients were
smokers, i.e. 86.5% (278/321) of male and only 17.4% (6/
31) of female patients.
Squamous cell carcinoma was the most common type
of lung cancer detected in 43% (139/321) of patients, i.e.
46% of male and 17.8% of female patients. The next form
was small cell anaplastic cancer in 27.5% (97/352), equally
present in male and female patients. The most common
type of lung cancer in women was adenocarcinoma in 51%
(16/31), which in male patients was on the third place
with 20.2% (65/321). Undifferentiated and other cancer
forms were found in 8.2% of patients.
During the second three-year study period, 682 pa-
tients were treated for lung cancer: 590 (85.3 %) male and
88 (14.7%) female. The male/female ratio was 7.1:1.
Squamous cell lung carcinoma was still on the lead
with 45.4% (311/682) of patients, i.e. 52% (311/590) of
male and 22.6% (20/88) of female patients. In women,
adenocarcinoma was on the first place with 51.1% (45/88),
K. Miπe et al. 3rd Congress of Croatian Society of Radiology with International Participation
Acta clin Croat, Vol. 41, No. 1, 2002 89
and small cell anaplastic carcinoma on the second place
with 26% (23/88) of patients.
During the third, postwar study period, 1017 patients
suffering from lung cancer were treated, 1011 of them
being evaluated: 889 (87.8%) male and 122 (12.2%) fe-
male. The male/female ratio was 7.3:1 (p<0.01). The mean
age was 63.0 years (x=63.40 + 10.2) for male and 65.5
years (c=65.51+ 1.4; p<0.04) for female patients.
Figure 1 shows the disease incidence rate for 5-year
age groups. Bronchial and lung cancer are extremely rare
before 40 years of age, so we found only 18 (1.8%) affected
persons. In the next five-year age group (40-45), the in-
cidence increased to 37 (3.7%), and in the 46-50 age group
to 82 (8.1%). During the fifth decade of life, the number
of affected grew from 1.8% in the <40 age group to 12.8%
in the 40-50 age group. The highest incidence of 429
patients or 42.35% of all patients was recorded in the 61-
70 age group.
Squamous cell cancer is still a lung cancer with the
highest incidence in man, and was found in 41% (367/
889) of cases, being most frequently diagnosed in the 66-
70 age group with 24.1% (n=96) and 6l-65 age group with
18.6% (n=74) of patients. The second place was held by
adenocarcinoma with 271 (30.5%) patients. Small cell
anaplastic lung cancer was on the third place with 21.7%
(n=193) of cases, most frequently diagnosed in the 6l-65
age group (21.3%). In women, adenocarcinoma had the
highest incidence of 51.6% (63/122), followed by small
cell anaplastic cancer with 22% (27/122) and squamous
cell cancer with 20.4% (25/122) of patients. Adenocarci-
noma was most frequently found in the 66-75 age group
(41.6% of female patients), squamous cell carcinoma in
the 56-65 age group with 22%, and small cell anaplastic
cancer in the 66-70 age group with 28.7% of patients.
A history of smoking for more than 20 years was re-
corded in 917 (80.8%) patients, 85.3% (759/889) of male
and 47.5% (58/122) of female.
Discussion
Lung cancer is one of the rare diseases that have spread
during the last century at a pace incomparable in history:
less than 90 odd years have passed from the first descrip-
tion in the literature, and it has already imposed itself
during the last fifty years as a large and unresolvable medi-
cal and social problem worldwide9,10,12,15. Comparison of
results obtained 20 years ago and those collected for the
last three years leads to a conclusion that we are facing a
quickly spreading disease in Croatia. Smoking is without
doubt the major cause of lung cancer. Twenty years ago,
80.5% of patients were smokers, whereof 86.5% of male
and only 17.6% of female, as reported by Miπe et al.1,7,8.
Certainly, smokers are most commonly affected by squa-
mous cell carcinoma (92% of cases). A most recent study
showed no decrease in smokers (84.7% of total number);
however, the number of female patients who were smok-
ers increased from 17.6% to 47%. Zelicort et al. also re-
port on an increase in women smokers who fell ill from
lung cancer to 56% in France from 1985 to 19959. The
American and European authors also correlate smoking
with lung cancer: Williams reports that 85%-90% of lung
cancer patients in America are smokers10, and Sobue’s
data for Japan show 90%17, and Buiatti’s for Italy 80%-
85% of smokers18 as lung cancer patients. Our data cor-
respond with the global data by approximately 85%. How-
ever, some authors like Wynder19 and Francheschi12 write
about a decreasing number of smokers in the USA, Den-
mark and north Italy since 1990, and a small decrease in
lung cancer incidence in men but not in women. On the
contrary, lung cancer in women is on an increase, particu-
larly in south and southeast Europe. The data recorded for
our region correspond with the global trends.
Lung cancer is a disease affecting male population
from the high-risk group that include men over 45 years
of age, those who smoke more that 20 cigarettes a day for
more than 20 years, and persons exposed to detrimental
carcinogenic substances. This can be confirmed by analysis
of lung cancer incidence according to age groups (Fig. 1),
which shows that it is extremely rare before 40 years of
age (1.8%), and rare before 45 years of age (4.5%). Total
number of persons affected before 50 years of age in our
study was 11.8%, and Ramalingam et al. report on 9% of
patients younger than 5015. Early lung cancer diagnosis
is a problem, since patients mostly contact their doctors
late, once they have already developed clinical and sub-
jective problems. This calls for a national multi-level
multidisciplinary strategy for lung cancer prevention,
similar to the one implemented in Japan17.
Twenty years ago, most patients were aged 61-65,
whereas lately this has changed to 65-70 years of age, with
most (42.3%) of patients in the seventh decade of life. In
Moscow, over 50% of female patients with lung cancer are
over 70 years of age23.
Twenty years ago, 91.2% of patients were male and
only 8.8% female. The male/female ratio was significantly
unfavorable for men because only one woman was re-
corded per more than 10 affected men (10.4:1; p<0.0002)7.
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However, this ratio has changed during the last decade
with 87.9% of male and 12.1% female patients and the
male/female ratio of 7.3:1 (p<0.001) (Fig. 2). There is a
noticeable increase in the incidence of lung cancer in fe-
male patients. In other countries, it has been 3-5:1 for
years6,16,23. In Croatia, this number has increased mainly
due to the increase in the number of female smokers.
Negri reports on an increase in lung cancer in women in
south Europe by 24%, and in east Europe by 32%, as the
result of an increased number of female smokers20,23.
Comparison of the results obtained 20 years ago with
those for the last three years shows an increase in the in-
cidence of lung cancer in men and even more in women,
both in Croatia and worldwide: by 2.4 times in male and
4.1 times in female population (Fig. 3).
Recently, changes have been recorded in the distribu-
tion of different types of lung cancer, with squamous cell
carcinoma remaining in the leading position but with a
slightly decreasing trend (from 45% to 43.4%) (p<0.34).
A significant increase in the incidence of adenocarcinoma
was noticed (from 20.3% to 30.5%; p<0.0005), which was
Fig. 1. Age distribution of lung carcinoma patients
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due to the increase in the rate of adenocarcinoma in men
since the number of affected women practically remained
unchanged (51%). Small cell anaplastic carcinoma was on
a significant decrease (from 27% to about 21%; p<0.01).
There was an increase in the rate of squamous cell carci-
noma in women (from 17.8% to 20.4%; p<0.03). Many
authors report on a significant increase in lung adenocar-
cinoma in general, and in smokers as well, on the account
of a decrease in the squamous cell carcinoma morbid-
ity11,14,17,19,20,22. This has been attributed to the new de-
sign and technology in the manufacture of filter cigarettes,
so called “light or low-yield” cigarettes with finer nicotine
particles that penetrate deeper into the lungs and reach
the periphery in higher quantities. The substance N-nit-
rosamine from nicotine may be inducing lung adenocar-
cinoma. Other provocation factors could also be added,
such as specific living conditions in the analyzed area (re-
gion) during the last 10 years, caused by war and postwar
events, and enormous psychical stress. This could be a
provocation factor that contributed to the increase in the
incidence of adenocarcinoma in male population. It
should not be neglected that the diagnosis of small periph-
eral pulmonary lesions have improved over the last 20
years since the CT guided fine-needle aspiration biopsy
of lungs has come into use. All these factors could be the
cause of increase in the incidence of lung adenocarcinoma.
Other types of lung carcinoma were rare, most often un-
differentiated carcinoma (7%-8.9%).
During the war years of 1992 and 1993, a slight de-
crease in the morbidity compared to 1991 was noticed in
our region, which was probably a consequence of large
migration and immigration of the population caused by
war, which entailed an increased admission of patients,
refugees and displaced persons from the neighboring
Bosnia and Herzegovina to the Department.
In the west European countries and United States of
America, a decrease in the lung cancer morbidity rate has
been consistently recorded, particularly due to intensive
antismoking campaigns and ban on the use of asbestos and
its products introduced in USA introduced 30 years
ago18,21, whereas some European countries have only re-
cently placed ban on asbestos processing. However, the
Croatian asbestos industry is still operating, although as-
bestos is being imported.
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Saæetak
EPIDEMIOLO©KA ANALIZA RAKA PLU∆A U PODRU»JU SREDNJE DALMACIJE
(20-godiπnji rezultati)
K. Miπe, A. BradariÊ, A. SviliËiÊ, M. VuËkoviÊ, S. Kotarac, S. TomiÊ i S. JankoviÊ
Porast raka pluÊa zadnjih 20 godina oπit je i u naπem podruËju, i to viπestruko. ©iri se iz godine u godinu, kako u muπkaraca
tako i u æena. Biljeæi se porast u muπkaraca za 2,4 puta, a u æena Ëak za 4,2 puta. NajveÊi broj oboljelih su bili dugogodiπnji
puπaËi. Ova navika bila je joπ prije 30-tak godina znaËajka muπkaraca, a sada sve viπe i æena (porast bolesnica koje su puπile
od 17,8% na 47,3%). NajveÊi broj oboljelih je iznad 65. godine æivota, a zajedno s brojem onih iznad 60. godine æivota Ëine
preko 42% oboljelih. Dokazana je poveÊana uËestalost adenokarcinoma, koji nije bio u izravnoj vezi s puπenjem, na raËun pada
broja uËestalosti planocelularnog raka pluÊa. NajveÊi porast nalazi se u poratnim godinama (2000. g. Ëak 32%), a za taj porast
mogli bismo kriviti teπke psihiËke traume i ostale æivotne nedaÊe u ratu i nakon njega. Porast planocelualrnog raka u æena (sa
l7,5% na 20,4%) je vjerojatno zbog veÊeg broja æena koje su puπile. Biljeæi se pad mikrocelularnog anaplastiËnog raka pluÊa,
koji je podjednako zastupljen u oba spola (s 27% na 22,6%) oboljelih. UsporeujuÊi iznesene podatke iz jednoga dijela Hrvatske
(priobalnog podruËja) s podacima iz svijeta moæemo zakljuËiti da su epidemioloπki podaci sliËni onima iz podruËja juæne i
jugoistoËne Europe (juæne Italije, ©panjolske, GrËke).
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